Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             119 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine Zhornitsky, Simon
 2010
 20 Supplement 1 p. 695-703
9 p.
 artikel
2 An in vivo pharmacological evaluation of pardoprunox (SLV308) — A novel combined dopamine D2/D3 receptor partial agonist and 5-HT1A receptor agonist with efficacy in experimental models of Parkinson's disease Jones, C.A.
 2010
 20 Supplement 1 p. 582-593
12 p.
 artikel
3 Blood–brain barrier penetration of the enantiomers of venlafaxine and its metabolites in mice lacking P-glycoprotein Karlsson, Louise
 2010
 20 Supplement 1 p. 632-640
9 p.
 artikel
4 C.07.02 Pharmacogenetics of antidepressants Mendlewicz, J.
 2010
 20 Supplement 1 p. S642-
1 p.
 artikel
5 CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls Moreno, Francisco A.
 2010
 20 Supplement 1 p. 18-24
7 p.
 artikel
6 C.05.02 The patient journey: acute mania through to remission Young, A.
 2010
 20 Supplement 1 p. S640-S641
2 p.
 artikel
7 Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder Tauscher, Johannes
 2010
 20 Supplement 1 p. 80-87
8 p.
 artikel
8 ECNP Announcement: Call for Symposium Proposals, Paris, 2010 2010
 20 Supplement 1 p. II-
1 p.
 artikel
9 ECNP Announcement: Incentives - Young Scientists 2010
 20 Supplement 1 p. II-
1 p.
 artikel
10 ECNP Calendar of Events 2010
 20 Supplement 1 p. I-
1 p.
 artikel
11 E.01.02 Compulsivity across psychiatric disorders Denys, D.
 2010
 20 Supplement 1 p. S209-
1 p.
 artikel
12 Endogenous cannabinoids in post-mortem brains of Cloninger type 1 and 2 alcoholics Lehtonen, Marko
 2010
 20 Supplement 1 p. 245-252
8 p.
 artikel
13 Heroin-assisted treatment in the Netherlands: History, findings, and international context Blanken, Peter
 2010
 20 Supplement 1 p. S105-S158
54 p.
 artikel
14 Keyword Index 2010
 20 Supplement 1 p. S669-S675
7 p.
 artikel
15 P.4.a.004 A comparison of different types of obsessions due to brain damage Margaryan, S.
 2010
 20 Supplement 1 p. S522-S523
2 p.
 artikel
16 P.8.a.008 Agressivity management in mobile emergency unit Alvaro, P.
 2010
 20 Supplement 1 p. S633-S634
2 p.
 artikel
17 P.1.a.012 Association of aggressive traits with the 5-HTTLPR polymorphism in depressed and healthy women Gonda, X.
 2010
 20 Supplement 1 p. S219-
1 p.
 artikel
18 P.1.a.009 Association study of DISC1 gene with cognitive functions in Korean schizophrenia patients and healthy controls Park, D.
 2010
 20 Supplement 1 p. S217-
1 p.
 artikel
19 P.3.007 Abnormalities in reward prediction error signals in depression and schizophrenia Gradin, V.B.
 2010
 20 Supplement 1 p. S67-S68
2 p.
 artikel
20 P.3.a.038 Cannabis-induced psychosis: new entity? Makkos, Z.
 2010
 20 Supplement 1 p. S450-S451
2 p.
 artikel
21 P.7.a.010 Comorbidity in patients with attention deficit hyperactivity disorder in psychiatric population in prison Sanz-Garcia, O.
 2010
 20 Supplement 1 p. S616-
1 p.
 artikel
22 P.3.024 Addiction proneness: contribution of the endocannabinoid system and reward processing van Hell, H.H.
 2010
 20 Supplement 1 p. S82-
1 p.
 artikel
23 P.2.a.027 Effects of the serotonin type 3A receptor and the cytochrome 2D6*10 genes on citalopram efficacy and side effects in major depressive disorder Paik, J.
 2010
 20 Supplement 1 p. S349-
1 p.
 artikel
24 P.6.a.007 Influence of neuroactive peptidic preparations on apoptosis of immunocompetent cells in alcoholic patients Bokhan, N.
 2010
 20 Supplement 1 p. S574-
1 p.
 artikel
25 P.7.a.007 Intelligence and neurocognitive functioning by Korean Personality Inventory for Children (KPI-C), profile type in children with ADHD Kim, J.S.
 2010
 20 Supplement 1 p. S614-S615
2 p.
 artikel
26 Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice Sasso, Oscar
 2010
 20 Supplement 1 p. 195-206
12 p.
 artikel
27 P.4.a.001 Quality of life outcomes in obsessive-compulsive disorder: relationship to treatment response and symptom relapse Fineberg, N.A.
 2010
 20 Supplement 1 p. S520-S521
2 p.
 artikel
28 P.5.a.009 Relationship between subjective memory complaints and cognitive function in the elderly Lim, K.Y.
 2010
 20 Supplement 1 p. S554-S555
2 p.
 artikel
29 P.3.a.024 Risk for coronary heart disease in inpatients with serious mental illness Ntounas, P.
 2010
 20 Supplement 1 p. S442-S443
2 p.
 artikel
30 P.6.a.004 Serum glutamate dehydrogenase in alcoholics Kravos, M.
 2010
 20 Supplement 1 p. S572-
1 p.
 artikel
31 P.3.a.007 Subjective well-being in schizophrenia is inversely correlated with the presence and severity of depressive symptoms Sanjuan, J.
 2010
 20 Supplement 1 p. S433-S434
2 p.
 artikel
32 P.2.a.010 The cortisol awakening response in patients remitted from depression Aubry, J.M.
 2010
 20 Supplement 1 p. S339-
1 p.
 artikel
33 P.1.a.010 The role of sigma-1 receptor polymorphism in the pathogenesis of Alzheimer's disease: preliminary results Juhasz, A.
 2010
 20 Supplement 1 p. S218-
1 p.
 artikel
34 P.3.a.010 Visual processing abnormalities as biomarker for schizophrenia: an EEG study in the schizophrenia spectrum Koychev, I.
 2010
 20 Supplement 1 p. S435-
1 p.
 artikel
35 P.4.b.012 Acute anxiolytic drug treatment has no effect on the instrumental successive negative contrast effect using a modified forced choice serial reaction time task Mitchell, E.N.
 2010
 20 Supplement 1 p. S536-
1 p.
 artikel
36 P.2.b.020 Changes in gene expression in the rat brain induced by partial serotonergic denervation and chronic variable Alttoa, A.
 2010
 20 Supplement 1 p. S364-S365
2 p.
 artikel
37 P.2.b.017 Defining endophenoypes in major depressive disorder: anhedonia, neuroticism and psychomotor speed Vrieze, E.
 2010
 20 Supplement 1 p. S362-S363
2 p.
 artikel
38 P.4.b.003 Distinct role of the ventral hippocampus in two different animal models of anxiety Amaral, V.C.S.
 2010
 20 Supplement 1 p. S531-
1 p.
 artikel
39 P.1.b.001 Repetitive transcranial magnetic stimulation (rTMS) in the treatment of neuropatic pain Klirova, M.
 2010
 20 Supplement 1 p. S227-S228
2 p.
 artikel
40 P.3.b.001 Seasonality of serum melatonin concentrations in paranoid schizophrenic inpatients Mesa, E. Díaz
 2010
 20 Supplement 1 p. S452-
1 p.
 artikel
41 P.2.b.007 Time defining effects of tryptophan depletion on hormone secretion and brain 5-HT2 binding in the rat Franklin, M.
 2010
 20 Supplement 1 p. S357-
1 p.
 artikel
42 P.1.c.001 Acute psychomotor, memory and subjective effects of MDMA and THC (co-) administration over time in healthy volunteers Dumont, G.
 2010
 20 Supplement 1 p. S235-S236
2 p.
 artikel
43 P.1.c.063 Alpha-1-noradrenergic receptor blockade in OCD: an open label add-on study with prazosin Figee, M.
 2010
 20 Supplement 1 p. S271-
1 p.
 artikel
44 P.2.c.026 Antidepressants for late-life depression: a meta analysis of placebo-controlled randomized trials Tedeschini, E.
 2010
 20 Supplement 1 p. S382-S383
2 p.
 artikel
45 P.3.c.005 Association of antipsychotic polypharmacy with health service cost – a Danish register-based cost-minimisation analysis Baandrup, L.
 2010
 20 Supplement 1 p. S460-S461
2 p.
 artikel
46 P.3.c.019 Community treatment orders and psychotropic medication: baseline data analysis for a one year follow up study (N= 200) Patel, M.X.
 2010
 20 Supplement 1 p. S468-S469
2 p.
 artikel
47 P.3.c.022 Comparison of patients treated with antipsychotics and psychoeducation and those treated with antipsychotics only Istikoglou, C.
 2010
 20 Supplement 1 p. S470-
1 p.
 artikel
48 P.6.c.001 Cortisol levels and MDMA-induced memory impairment Kuypers, K.P.C.
 2010
 20 Supplement 1 p. S581-S582
2 p.
 artikel
49 P.4.c.006 Day 3&7 jitteriness symptoms predict poor 6 week outcome in SSRI treatment and correlate with day 7 nocturnal activity Christmas, D.
 2010
 20 Supplement 1 p. S544-S545
2 p.
 artikel
50 P.1.c.064 Decreased neuregulin-1 in the cortex of rat pups as immediate effect of perinatal phencyclidine treatment Petronijevic, N.
 2010
 20 Supplement 1 p. S271-S272
2 p.
 artikel
51 P.1.c.004 Defensive effects of polyprenol-containing drug ropren in a model of subacute hepatosis with encephalopathy in rats Shabanov, P.D.
 2010
 20 Supplement 1 p. S237-
1 p.
 artikel
52 P.3.c.046 Efficacy and safety of JNJ 37822681, a fast dissociating D2 receptor antagonist, in the treatment of schizophrenia Schmidt, M.
 2010
 20 Supplement 1 p. S484-S485
2 p.
 artikel
53 P.1.c.045 Ex-vivo serotonin 5-HT1A and 5-HT2A receptor occupancy by asenapine: comparison to olanzapine and risperidone Choi, Y.K.
 2010
 20 Supplement 1 p. S260-S261
2 p.
 artikel
54 P.3.c.032 Long-acting risperidone injection versus conventional depots in chronic psychotic patients: a 54 months study Guillena, S.L. Romero
 2010
 20 Supplement 1 p. S476-
1 p.
 artikel
55 P.1.c.014 MBDB, a recreational drug similar to MDMA, exhibits anxiogenic-like effects in mice tested in the elevated plus-maze Muela, A.t.
 2010
 20 Supplement 1 p. S243-
1 p.
 artikel
56 P.3.c.017 Polish patients of the EUFEST study after 1 year antipsychotic treatment: drug discontinuation and metabolic syndrome parameters Rabe-Jablonska, J.
 2010
 20 Supplement 1 p. S467-
1 p.
 artikel
57 P.3.c.063 QoL, global functioning and social adaptation of schizophrenic subjects treated with long-acting risperidone Golubovic, S. Tosic
 2010
 20 Supplement 1 p. S494-
1 p.
 artikel
58 P.1.c.059 Role of acetylcholine-mediated neurotransmission within pedunculopontine tegmental nucleus in the post-ictal analgesia de Oliveira, R.C.
 2010
 20 Supplement 1 p. S268-S269
2 p.
 artikel
59 P.7.c.007 Self-injury among Croatian adolescents: important risk factors Dodig-Curkovic, K.
 2010
 20 Supplement 1 p. S624-
1 p.
 artikel
60 P.2.c.023 Sleep architecture in olanzapine treated patients with depression: a double blind randomized placebo controlled trial Milev, R.
 2010
 20 Supplement 1 p. S380-S381
2 p.
 artikel
61 P.2.c.009 The effect of major depression, SSRI and gepirone-extended-release treatment on sexual function in women Fabre, L.
 2010
 20 Supplement 1 p. S372-S373
2 p.
 artikel
62 P.1.c.028 The effects of atypical antipsychotic drugs on regulation of cell cycle against MPP+-induced apoptosis in PC12 cells Kim, Y.H.
 2010
 20 Supplement 1 p. S250-S251
2 p.
 artikel
63 P.1.c.042 The effects of variation in magnesium soft matter vesicles dosage on behavioural manifestation in rats Tartau, L.
 2010
 20 Supplement 1 p. S259-
1 p.
 artikel
64 P.3.010 CYP2D6 and CYP2C19 genotypes predict antidepressant dose in the GENDEP project Keers, R.
 2010
 20 Supplement 1 p. S70-S71
2 p.
 artikel
65 P.3.d.012 Action of clozapine depends on dopamine receptors presence on target cells -functional study Faron-Gorecka, A.
 2010
 20 Supplement 1 p. S504-
1 p.
 artikel
66 P.2.d.001 Antidepressant properties of ketamine plus imipramine treatment: behavioural and molecular studies in rats Réus, G.Z.
 2010
 20 Supplement 1 p. S391-
1 p.
 artikel
67 P.5.d.001 1-Benzyl-1,2,3,4-tetrahydroisoquinoline inhibits L-DOPA-induced increase of dopamine metabolism in rat brain Wasik, A.
 2010
 20 Supplement 1 p. S563-S564
2 p.
 artikel
68 P.1.d.023 Effect of sex hormones on pain-related behaviour in rats Shekunova, E.
 2010
 20 Supplement 1 p. S286-
1 p.
 artikel
69 P.1.d.009 Longterm memory formation in non-association learning task in sham-operated and dentate gyrus lesioned rats Naneishvili, T.
 2010
 20 Supplement 1 p. S278-S279
2 p.
 artikel
70 P.1.d.026 Nicotine ameliorates behavioural deficits and oxidative stress in a 6-hydroxydopamine rat model of Parkinson's disease Ciobica, A.
 2010
 20 Supplement 1 p. S288-
1 p.
 artikel
71 P.3.d.009 Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia Langlois, X.
 2010
 20 Supplement 1 p. S502-
1 p.
 artikel
72 P.2.d.016 Postweaning enriched environment and citalopram overcome memory deficits and anhedonia induced by maternal separation Zhang, Z.
 2010
 20 Supplement 1 p. S399-S400
2 p.
 artikel
73 P.2.d.019 Prefrontal oscillation associated with randomised, placebo-controlled treatment with agomelatine and psychotherapy Loza, B.
 2010
 20 Supplement 1 p. S401-
1 p.
 artikel
74 P.1.d.025 The involvement of oxidative stress in some cognitive effects of angiotensin II and angiotensin 1–7 in rats Ciobica, A.
 2010
 20 Supplement 1 p. S287-S288
2 p.
 artikel
75 P.2.d.003 The omega-3 polyunsaturated fatty acid docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia Su, K.
 2010
 20 Supplement 1 p. S392-S393
2 p.
 artikel
76 P.5.d.002 The protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on rotenone-induced irregularities in rat brain Antkiewicz-Michaluk, L.
 2010
 20 Supplement 1 p. S564-S565
2 p.
 artikel
77 P.6.d.014 The severity of morphine abstinence correlates with brain FADD phosphorylation: interaction with α2-adrenoceptors Ramos-Miguel, A.
 2010
 20 Supplement 1 p. S596-
1 p.
 artikel
78 P.6.d.017 Tiagabine prevents changes in alpha(1)-adrenoceptor subtypes induced by cocaine sensitization: immunohistochemical study Kusmierczyk, J.
 2010
 20 Supplement 1 p. S597-S598
2 p.
 artikel
79 P.6.d.004 Transient inactivation of nucleus accumbens reduces morphine place preference in rats Sahraei, H.
 2010
 20 Supplement 1 p. S590-
1 p.
 artikel
80 P.6.e.003 Acute psychotic disorder due to the use of ethnobotanical substances Ladea, M.
 2010
 20 Supplement 1 p. S606-
1 p.
 artikel
81 P.1.e.026 [11C]AF150(S): a putative agonist PET ligand for in vivo imaging of the M1 muscarinic acetylcholine receptor Leysen, J.E.
 2010
 20 Supplement 1 p. S302-S303
2 p.
 artikel
82 P.3.e.009 Clinical analysis of the treatment of schizophrenia (CATS)-study: module assessment of sexual functions Lautenschlager, M.
 2010
 20 Supplement 1 p. S512-
1 p.
 artikel
83 P.3.e.003 Effectiveness of olanzapine standard oral and orally disintegrating tablets in a 1-year European observational study Chartier, F.
 2010
 20 Supplement 1 p. S508-S509
2 p.
 artikel
84 P.2.e.013 Effectiveness of quetiapine in bipolar depression patients: a multi-centre, prospective, open-label, observational study Jeong, J.
 2010
 20 Supplement 1 p. S409-
1 p.
 artikel
85 P.1.e.015 Emotion cognition interaction located using surface-based versus volume-based analysis Huf, W.
 2010
 20 Supplement 1 p. S296-S297
2 p.
 artikel
86 P.1.023 Effect of antidepressants on lipopolysaccharide-induced interleukin-1β levels in brain and plasma of rats Prymus, A.
 2010
 20 Supplement 1 p. S20-S21
2 p.
 artikel
87 P.4.e.001 Lost productivity time among workers with panic disorder and the improvement after 12 weeks of pharmacotherapy Woo, J.
 2010
 20 Supplement 1 p. S546-S547
2 p.
 artikel
88 P.1.g.008 Cognitive effects of electrode placement and stimulus dose in brief-pulse electroconvulsive therapy for depression Semkovska, M.
 2010
 20 Supplement 1 p. S312-S313
2 p.
 artikel
89 P.1.g.022 Decision-making in euthymis bipolar disorders: their relationship with suicidal behaviour Martino, D.J.
 2010
 20 Supplement 1 p. S320-S321
2 p.
 artikel
90 P.2.g.008 Efficacy of milnacipran in patients with interferon-a2 induced depression Zavoianu, M.
 2010
 20 Supplement 1 p. S425-
1 p.
 artikel
91 P.1.g.005 Frontal lobe functions in patients with juvenile myoclonic epilepsy treated with valproate or lamotrigine Jovic, N.
 2010
 20 Supplement 1 p. S311-
1 p.
 artikel
92 P.2.023 Glycine transporter 1 disruption restricted to the nucleus accumbens is sufficient to enhance latent inhibition Peleg-Raibstein, D.
 2010
 20 Supplement 1 p. S47-S48
2 p.
 artikel
93 P.1.013 Glycogen synthase kinase-3β inhibition blocks the effect of IL-1β on hippocampal neural precursor cell differentiation Green, H.
 2010
 20 Supplement 1 p. S13-
1 p.
 artikel
94 P.1.i.006 Clinical experience with electroconvulsive therapy at the university hospital in South Korea Kim, H.C.
 2010
 20 Supplement 1 p. S331-
1 p.
 artikel
95 P.1.014 Identification of a mouse febrile seizure susceptibility gene Hessel, E.V.S.
 2010
 20 Supplement 1 p. S13-S14
2 p.
 artikel
96 P.1.i.003 Examination of the effects of stimulant treatment across the adult lifecycle of adults with ADHD: a controlled study Biederman, J.
 2010
 20 Supplement 1 p. S329-
1 p.
 artikel
97 P.2.017 Mice lacking two key phosphorylation sites on the GluR1 subunit exhibit decreased anxiety-like behaviour Kiselycznyk, C.
 2010
 20 Supplement 1 p. S42-S43
2 p.
 artikel
98 P.2.031 Neonatal estradiol administration to female rats alters adult benzodiazepine sensitivity Santoru, F.
 2010
 20 Supplement 1 p. S54-
1 p.
 artikel
99 P.2.014 Neonatal influenza A infection potentiates amphetamine induced increase in locomotor activity in the adult mouse Holtze, M.
 2010
 20 Supplement 1 p. S40-
1 p.
 artikel
100 P.1.017 Netrin G1 polymorphisms in cocaine and alcohol codependence vulnerability: from mice to men Kelai, S.
 2010
 20 Supplement 1 p. S16-
1 p.
 artikel
101 P.4.004 Stress-induced alterations in hippocampal microRNAs: effects of lithium O'Connor, R.M.
 2010
 20 Supplement 1 p. S93-
1 p.
 artikel
102 P.1.032 Study of the effect of acute stress on glutamate release in prefrontal/frontal cortex of antidepressant treated rats Zagaria, N.
 2010
 20 Supplement 1 p. S27-S28
2 p.
 artikel
103 Retrograde facilitation of verbal memory by trihexyphenidyl in healthy elderly with and without the APOE ε4 allele Pomara, Nunzio
 2010
 20 Supplement 1 p. 467-472
6 p.
 artikel
104 S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: A comparison to aprepitant (MK869) and paroxetine Millan, Mark J.
 2010
 20 Supplement 1 p. 599-621
23 p.
 artikel
105 S.19.05 Affective and cognitive aspects of pain processing in borderline personality disorder Schmahl, C.
 2010
 20 Supplement 1 p. S192-
1 p.
 artikel
106 S.21.05 Antipsychotic-related metabolic and endocrine adverse events in pediatric patients: frequency, monitoring and management strategies Correll, C.
 2010
 20 Supplement 1 p. S196-
1 p.
 artikel
107 S.08.02 Chronic stress, depressive disorders and obesity: insights from animal models Bartolomucci, A.
 2010
 20 Supplement 1 p. S175-
1 p.
 artikel
108 S.25.05 Erythropoietin and neuroprotection Ehrenreich, H.
 2010
 20 Supplement 1 p. S202-S203
2 p.
 artikel
109 S.16.04 Formation of N-acylethanolamines in the brain: where and when? Hansen, H.
 2010
 20 Supplement 1 p. S187-
1 p.
 artikel
110 S.05.04 Glucocorticoids and noradrenaline in severe stress exposure in humans Schelling, G.
 2010
 20 Supplement 1 p. S169-S170
2 p.
 artikel
111 S.12.05 5-HT2C receptor ligands in the treatment of obesity and type 2 diabetes Heisler, L.K.
 2010
 20 Supplement 1 p. S182-
1 p.
 artikel
112 S.04.08 Impulsive decision making predicts resistance to extinction of cocaine seeking and enhanced vulnerability to cue-induced relapse Broos, N.
 2010
 20 Supplement 1 p. S168-
1 p.
 artikel
113 S.12.01 Physiological and therapeutic relevance of constitutive activity at 5-HT2C receptors Spampinato, U.
 2010
 20 Supplement 1 p. S181-
1 p.
 artikel
114 S.02.04 Physiopathological features of tauopathies and tau transgenic mice Buée, L.
 2010
 20 Supplement 1 p. S163-
1 p.
 artikel
115 S.22.04 Predictors of functioning in bipolar disorder Dittmann, S.
 2010
 20 Supplement 1 p. S197-
1 p.
 artikel
116 S.1.02 The neuropharmacology of impulsive behaviour with focus on translational aspects Pattij, T.
 2010
 20 Supplement 1 p. S1-S2
2 p.
 artikel
117 The β3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes Tamburella, Alessandra
 2010
 20 Supplement 1 p. 704-713
10 p.
 artikel
118 The risk of death among adult participants in trials of antipsychotic drugs in schizophrenia 1 1 The views expressed in this article are the personal views of the author(s) and may not be understood or quoted as being made on behalf of or reflecting the position of the EMEA or one of its committees or working parties or the BfArM. Isaac, Maria
 2010
 20 Supplement 1 p. 139-145
7 p.
 artikel
119 The selective 5-HT1A receptor antagonist NAD-299 increases acetylcholine release but not extracellular glutamate levels in the frontal cortex and hippocampus of awake rat Kehr, Jan
 2010
 20 Supplement 1 p. 487-500
14 p.
 artikel
                             119 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland